INVO Bioscience Statistics
Total Valuation
INVO has a market cap or net worth of $2.73 million. The enterprise value is $14.67 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, after market close.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INVO has 3.91 million shares outstanding. The number of shares has increased by 329.85% in one year.
| Shares Outstanding | 3.91M |
| Shares Change (YoY) | +329.85% |
| Shares Change (QoQ) | -5.05% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 3.11% |
| Float | 3.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 3.94.
| Current Ratio | 0.30 |
| Quick Ratio | 0.15 |
| Debt / Equity | 3.94 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.57% |
| Return on Capital (ROIC) | -64.46% |
| Revenue Per Employee | $192,318 |
| Profits Per Employee | -$236,164 |
| Employee Count | 30 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 12.00 |
Taxes
In the past 12 months, INVO has paid $26,757 in taxes.
| Income Tax | 26,757 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.98% in the last 52 weeks. The beta is 1.44, so INVO's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -9.98% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 43.99 |
| Average Volume (20 Days) | 45,216 |
Short Selling Information
The latest short interest is 58,870, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 58,870 |
| Short Previous Month | 121,331 |
| Short % of Shares Out | 1.51% |
| Short % of Float | 1.52% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
In the last 12 months, INVO had revenue of $5.77 million and -$7.08 million in losses. Loss per share was -$2.56.
| Revenue | 5.77M |
| Gross Profit | 2.59M |
| Operating Income | -5.24M |
| Pretax Income | -7.05M |
| Net Income | -7.08M |
| EBITDA | -4.62M |
| EBIT | -5.24M |
| Loss Per Share | -$2.56 |
Full Income StatementBalance Sheet
The company has $942,934 in cash and $5.38 million in debt, giving a net cash position of -$4.43 million or -$1.14 per share.
| Cash & Cash Equivalents | 942,934 |
| Total Debt | 5.38M |
| Net Cash | -4.43M |
| Net Cash Per Share | -$1.14 |
| Equity (Book Value) | 1.36M |
| Book Value Per Share | -1.59 |
| Working Capital | -5.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.68 million and capital expenditures -$288,046, giving a free cash flow of -$3.97 million.
| Operating Cash Flow | -3.68M |
| Capital Expenditures | -288,046 |
| Free Cash Flow | -3.97M |
| FCF Per Share | -$1.02 |
Full Cash Flow StatementMargins
Gross margin is 44.89%, with operating and profit margins of -90.89% and -122.80%.
| Gross Margin | 44.89% |
| Operating Margin | -90.89% |
| Pretax Margin | -122.33% |
| Profit Margin | -122.80% |
| EBITDA Margin | -80.16% |
| EBIT Margin | -90.89% |
| FCF Margin | -102.05% |